Novartis Vaccines and Diagnostics, 350 Massachusetts Ave., Cambridge, MA 02139, USA.
Vaccine. 2011 Aug 26;29(37):6262-8. doi: 10.1016/j.vaccine.2011.06.067. Epub 2011 Jun 30.
Emulsions have been used to boost immunogenicity of antigens since the discovery of complete Freunds adjuvant. Optimization to reduce reactogenicity of emulsion adjuvants lead to the development of oil in water emulsions based on squalene. MF59 is an oil-in-water emulsion that is a component of an approved influenza product in Europe. Currently MF59 is manufactured from squalene derived from an animal source. Recently a high purity plant-derived squalene source has become available at an appropriate purity for a vaccine adjuvant. The purpose of this study was to evaluate and compare animal-derived squalene and plant-derived squalene for equivalency. Nanoemulsions were prepared and analyzed for size and viscosity prepared from each source. The two emulsions were administered in two separate animal studies, one focusing on Neisseria meningitidis B, and one focusing on influenza. Readouts were ELISA titers for each antigen and serum bactericidal activity for N. meningitidis B, and hemagglutinin inhibition for influenza to see the functionality of the antibodies produced. Results indicate that there are no differences between the antibodies elicited after immunization from an emulsion made with oil derived from either an animal or plant-source.
自发现完全弗氏佐剂以来,人们一直将乳剂用于增强抗原的免疫原性。为了降低乳剂佐剂的反应原性而进行的优化,导致了基于角鲨烯的水包油乳剂的发展。MF59 是一种水包油乳剂,是欧洲批准的流感产品的成分。目前,MF59 是由源自动物源的角鲨烯制成的。最近,一种高纯度的植物源性角鲨烯源已可获得,其纯度适合用作疫苗佐剂。本研究的目的是评估和比较动物源性角鲨烯和植物源性角鲨烯的等效性。从每种来源制备纳米乳剂并分析其大小和粘度。将两种乳液分别在两项单独的动物研究中进行给药,一项针对脑膜炎奈瑟菌 B,另一项针对流感。针对每种抗原进行 ELISA 滴度检测,针对脑膜炎奈瑟菌 B 进行血清杀菌活性检测,针对流感进行血凝抑制检测,以观察所产生抗体的功能。结果表明,用源自动物或植物源的油制成的乳液进行免疫后,所产生的抗体之间没有差异。